Hamilton Thorne Announces Additional Accreditations for Its Embryotech Laboratories Subsidiary
October 15 2019 - 8:30AM
Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision
instruments, consumables, software and services to the Assisted
Reproductive Technologies (ART) and developmental biology research
markets, today reported that its Embryotech Laboratories Inc.
subsidiary has added Good Laboratory Practice (GLP) for
Non-Clinical Laboratory Studies to its ANSI National Accreditation
Board (ANAB) certificate of accreditation. Embryotech also
announces the addition of Human Sperm Motility Assay (SMA)
utilizing Computer Assisted Sperm Analysis (CASA) software to their
scope of accreditation during their reassessment of ISO 17025:2017.
Joel Lopez, Senior Vice President and General Manager of
Embryotech, stated, “We have added GLP accreditation in response to
customer demand for GLP studies to support their submissions to the
FDA for 510K clearance and to other regulatory bodies, which has
been a growing area of business for us. By adding these offerings
to our comprehensive suite of quality control testing services,
Embryotech cements its role as the leading testing services
provider to the Assisted Reproductive Technologies field. We
believe we are the only lab which is fully certified to do GLP
studies with the full array of ISO 17025:2017 accredited tests that
meet the needs of the ART field.”
Embryotech’s scope of accreditation includes testing of Raw
Materials, Media, and Devices Intended for use in the Medical
Industry, using the following tests or measurements:
- Mouse Embryo Assay (MEA): 1-cell and 2-cell method
- Mouse In Vitro Fertilization
- Human Sperm Survival Assay (HSSA)
- Sperm Motility Index (SM)
- Sperm Penetration Assay (SPA)
- Human Sperm Motility Assay (SMA) utilizing CASA software
- Endotoxin Testing (LAL): Gel-Clot and Kinetic method
- pH and Osmolality
Please visit our website for a full description of our
products and services at www.embryotech.com.
About Hamilton Thorne Ltd.
(www.hamiltonthorne.ltd)
Hamilton Thorne is a leading global provider of precision
instruments, consumables, software and services that reduce cost,
increase productivity, improve results and enable breakthroughs in
Assisted Reproductive Technologies (ART) and developmental biology
research markets. Hamilton Thorne markets its products and services
under the Hamilton Thorne, Gynemed, Planer and Embryotech
Laboratories brands, through its growing sales force and
distributors worldwide. Hamilton Thorne’s customer base consists of
fertility clinics, university research centers, animal breeding
facilities, pharmaceutical companies, biotechnology companies, and
other commercial and academic research establishments.
Neither the TSX Venture Exchange, nor its regulation services
provider (as that term is defined in the policies of the exchange),
accepts responsibility for the adequacy or accuracy of this
release.
Certain information in this press release may
contain forward-looking statements. This information is based on
current expectations that are subject to significant risks and
uncertainties that are difficult to predict including the risk that
the Company may not be able to obtain the necessary regulatory
approvals, as applicable. Actual results might differ materially
from results suggested in any forward-looking statements. The
Company assumes no obligation to update the forward-looking
statements, or to update the reasons why actual results could
differ from those reflected in the forward-looking statements
unless and until required by securities laws applicable to the
Company. Additional information identifying risks and uncertainties
is contained in filings by the Company with the Canadian securities
regulators, which filings are available at www.sedar.com
For more information, please
contact:
David Wolf, President & CEO Hamilton Thorne Ltd.
978-921-2050 ir@hamiltonthorne.ltd |
Michael Bruns, CFOHamilton Thorne Ltd. 978-921-2050
ir@hamiltonthorne.ltd |
Glen AkselrodBristol Investor
Relations416-737-4467glen@bristolir.com |
Hamilton Thorne (TSXV:HTL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Hamilton Thorne (TSXV:HTL)
Historical Stock Chart
From Apr 2023 to Apr 2024